Pharming Group N.V. (PHAR) stock
PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.60−0.35 (-2.70%)
Close on Nov 13, 2026Market cap $884.12MP/E 315.0Yield –
Pharming total assets
Total assets on the balance sheet at the end of each period.
Pharming's total assets was $499.96M at Dec 31, 2025. For fiscal 2025 it was $499.96M, up 25.0% from the year before. The highest annual figure on record is $499.96M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $499.96M | +25.0% |
| FY2024 | Dec 31, 2024 | $399.99M | -13.6% |
| FY2023 | Dec 31, 2023 | $462.85M | +8.7% |
| FY2022 | Dec 31, 2022 | $425.80M | +7.2% |
| FY2021 | Dec 31, 2021 | $397.32M | -5.1% |
| FY2020 | Dec 31, 2020 | $418.45M | +63.5% |
| FY2019 | Dec 31, 2019 | $255.92M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $499.96M | +25.8% |
| Q4 FY2024 | Dec 31, 2024 | $399.99M | -4.4% |
| Q4 FY2023 | Dec 31, 2023 | $462.85M | +80.9% |
| Q4 FY2022 | Dec 31, 2022 | $425.80M | – |
| Q4 FY2021 | Dec 31, 2021 | $397.32M | – |
| Q4 FY2020 | Dec 31, 2020 | $418.45M | – |
| Q4 FY2019 | Dec 31, 2019 | $255.92M | – |
See a number that looks wrong?